Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell NewsInnoCare Pharma announced that the Company has received Investigational New Drug approval of clinical trial from the National Medical Products Administration for its B cell lymphoma-2 inhibitor ICP-248.
[InnoCare Pharma]
Home Newsletters Immunology of Infectious Disease News InnoCare Announces Approval of Clinical Trial of BCL2 Inhibitor ICP-248 in China
